Ferozsons Laboratories Limited operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Ferozsons Laboratories Limited with three other
pharmaceutical manufacturers in Asia:
Novartis India Limited
sales of 8.08 billion Indian Rupees [US$118.50 million]
of which 81%
Searle Co Ltd
(11.29 billion Pakistan Rupees [US$107.72 million]
Claris Lifesciences Ltd
based in India
(7.54 billion Indian Rupees [US$110.57 million]
During the year ended June of 2016, sales at
Ferozsons Laboratories Limited were 11.34 billion Pakistan Rupees (US$108.14 million).
increase of 98.7%
versus 2015, when the company's sales were 5.71 billion Pakistan Rupees.
This was the fifth consecutive year of sales increases at Ferozsons Laboratories Limited
(and since 2011, sales have increased a total of 415%).